XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.2
Capital Stock Repurchase Plan Transactions
 6 Months Ended
Jun. 30, 2024
Capital Stock Repurchase Plan Transactions [Abstract]  
Capital Stock Repurchase Plan Transactions 16.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

Three months ended June 30,

Six months ended June 30,

2024

2023

2024

2023

Total cost of repurchased shares (in thousands)

$

55,769 

$

13,425 

$

88,113 

$

13,425 

Shares repurchased

100,000 

25,000 

150,000 

25,000 

Weighted average price per share

$

557.68 

$

536.98 

$

587.41 

$

536.98 

In November 2023, the Board of Directors authorized $300.0 million for additional stock repurchase under the February 2011 repurchase program. In May and November 2021, the Board of Directors authorized a total of $600.0 million for additional stock

repurchase under Chemed’s existing share repurchase program. We currently have $225.9 million of authorization remaining under this share repurchase plan.